cas 915087-32-0|| where to buy 4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

Nom du produit:4-(2-CYANOPROPAN-2-YLAMINO)-2-FLUORO-N-METHYLBENZAMIDE

IUPAC Name:4-[(1-cyano-1-methylethyl)amino]-2-fluoro-N-methylbenzamide

Unité d'emballage	Stock disponible	Prix($)
CM329948-100mg	in stock	ȃůȃ
CM329948-250mg	in stock	ƥůȃ
CM329948-1g	in stock	ůŗŹ
CM329948-5g	1-2 Weeks	ȃƓĲȃ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 915087-32-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:915087-32-0; Formule moléculaire:C12H14FN3O; Point de fusion:-; Code SMILES:O=C(NC)C1=CC=C(NC(C)(C#N)C)C=C1F; Densité:

: Numéro de catalogue:CM329948; Poids moléculaire:235.26; Point d'ébullition:; N° Mdl:; Stockage:

: Enzalutamide; Aug. 23, 2023, FDA grants priority review for XTANDI(enzalutamide) in non-metastatic castration-sensitive prostate cancer with high-risk biochemical recurrence.
XTANDI (enzalutamide) is an androgen receptor signaling inhibitor. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.XTANDI is currently approved for one or more of these indications in more than 100 countries, including in the U.S., European Union and Japan. Over one million patients have been treated with XTANDI globally.